Clinical Trial Update: 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NPI-001 aimed at preserving photoreceptors in retinitis pigmentosa associated with Usher syndrome; the study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa
• Usher Syndrome

Drugs mentioned

• NPI-001

Snippet

Sponsor: Nacuity Pharmaceuticals, Inc. | Conditions: Retinitis Pigmentosa (RP), Usher Syndrome | Phase 3 | Status: NOT_YET_RECRUITING